Targeting Fibrotic Scarring by Mechanoregulation of Il11ra1 + /Itga11 + Fibroblast Patterning Promotes Axon Growth after Spinal Cord Injury
Advanced Science · 2025-11 · 12 (44)
DOI: 10.1002/advs.202513476 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, online erschienen am 09.09.2025. Verfasst von Longyou Xiao und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Spine Surgery, The 3rd Affiliated Hospital, Sun Yat-Sen University, Guangzhou, 510630, P. R. China. Hauptthemen laut MEDLINE: Spinal Cord Injuries, Mechanotransduction, Cellular, Cicatrix, Hydrogels. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Guangzhou Municipal Science and Technology Bureau, National Natural Science Foundation of China, Guangdong Provincial Department of Science and Technology.
Abstract (Originalsprache)
Fibrotic scarring remains a critic obstacle to axonal regeneration after spinal cord injury (SCI). Current strategies primarily concentrating on eliminating extracellular matrix (ECM) components neglect their dispensable roles in maintaining tissue integrity. Here, it is reported that the mechanical strength of an integrated hydrogel composed of hyaluronic acid‐graft‐dopamine and HRR peptide directs fibroblast migration, determining ECM deposition. The mechanical strength matching that of spinal cord induces fibroblast alignment, reshaping fibrotic scars into a parallel matrix, while the mechanical strength deviating from that of spinal cord fails to do so. Mechanical investigation identifies a previously unknown Il11ra1 + /Itga11 + fibroblast subset that is specially associated with aligned infiltration and parallel ECM via mechanotransduction signaling cascade LRP6/β‐Catenin/MMP7, promoting axonal regeneration and boosting neural reconnections across the lesion. The study uncovers the mechanotransduction mechanism that remodels fibrosis progression through manipulating cellular components of fibrotic scars, providing novel insights into discovering potential therapeutic targets to resolve fibrosis after SCI.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Spine Surgery, The 3rd Affiliated Hospital, Sun Yat-Sen University, Guangzhou, 510630, P. R. China.
- Guangdong-Hong Kong-Macau Institute of CNS Regeneration (GHMICR), Jinan University, Guangzhou, 510632, P. R. China.
- Department of Emergency, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, 510080, P. R. China.
- Centre of Regenerative Medicine and Health, Hong Kong Institute of Science & Innovation, Chinese Academy of Sciences, Hong Kong, 999077, P. R. China.
- Re-Stem Biotechnology Co., Ltd., Suzhou, 215129, P. R. China.
ORCID-Profile: Liumin He
Förderung
- Guangzhou Municipal Science and Technology Bureau
- National Natural Science Foundation of China
- Guangdong Provincial Department of Science and Technology
- Innovation and Technology Commission
Zitieren
APA
Xiao, L., Shi, K., Li, W., Liu, J., Xie, P., Hu, Z., Dai, Y., Weng, H., Yuan, Q., Wu, W., Rong, L., & He, L. (2025). Targeting Fibrotic Scarring by Mechanoregulation of Il11ra1 + /Itga11 + Fibroblast Patterning Promotes Axon Growth after Spinal Cord Injury. Advanced Science, 12(44). https://doi.org/10.1002/advs.202513476
Vancouver
Xiao L, Shi K, Li W, Liu J, Xie P, Hu Z, et al. Targeting Fibrotic Scarring by Mechanoregulation of Il11ra1 + /Itga11 + Fibroblast Patterning Promotes Axon Growth after Spinal Cord Injury. Advanced Science. 2025;12(44). doi:10.1002/advs.202513476
BibTeX
@article{Xiao2025,
author = {Xiao, Longyou and Shi, Kaixi and Li, Wen and Liu, Jialin and Xie, Pengfei and Hu, Zijun and Dai, Yu and Weng, Haiyan and Yuan, Qiuju and Wu, Wutian and Rong, Limin and He, Liumin},
title = {Targeting Fibrotic Scarring by Mechanoregulation of Il11ra1 + /Itga11 + Fibroblast Patterning Promotes Axon Growth after Spinal Cord Injury},
journal = {Advanced Science},
year = {2025},
volume = {12},
number = {44},
doi = {10.1002/advs.202513476}
}
EUVIMED